1. Serum Uric Acid and High-Sensitivity C-Reactive Protein as Predictors of Cognitive Impairment in Patients with Cerebral Infarction
   Fang Ran et al, 2020, Dementia and Geriatric Cognitive Disorders CrossRef
2. The effectiveness and safety of human urinary kallidinogenase in acute ischemic stroke patients undergoing endovascular therapy
   Mengmeng Wang et al, 2024, Journal of Cerebral Blood Flow & Metabolism CrossRef
3. Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension
   Danhong Wu et al, 2017, Brain and Behavior CrossRef
4. Intra-arterial human urinary kallidinogenase alleviates brain injury in rats with permanent middle cerebral artery occlusion through PI3K/AKT/FoxO1 signaling pathway
   Ning Ma et al, 2018, Brain Research CrossRef
5. Efficacy and safety of human urinary kallidinogenase for acute ischemic stroke: a meta-analysis
   Yuanxiang Huang et al, 2020, Journal of International Medical Research CrossRef
6. The application value of computed tomography perfusion imaging in diagnosing early cerebral infarction
   B. Sun et al, 2024, International Journal of Radiation Research CrossRef
7. Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery
   Dong Han et al, 2018, Brain and Behavior CrossRef
8. Effects of Urinary Kallidinogenase on NIHSS score, mRS score, and fasting glucose levels in acute ischemic stroke patients with abnormal glucose metabolism
   Lei Chen et al, 2019, Medicine CrossRef
9. Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
   Zhenyu Wei et al, 2018, Frontiers in Neurology CrossRef
10. Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis
    Di‐Xiao Yang et al, 2021, Brain and Behavior CrossRef
11. Efficacy and Safety of Dl-3-n-Butylphthalide Combined With Human Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke
    Yaqian Zhang et al, 2023, Clinical Neuropharmacology CrossRef